Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.6 / 5 stars · 61/118 Roast Me

IQVIA HOLDINGS INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

IQVIA HOLDINGS INC. (IQV) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.20 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-05

  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.20M shares, a 0.00% change year-over-year.
  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.80M shares, a 80.00% increase year-over-year.
  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 3.60M shares, a 227.27% increase year-over-year.
  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.20M shares, a 175.00% increase year-over-year.
  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.30M shares, a 130.00% increase from fiscal 2024.
  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.00M shares, a 0.00% change from fiscal 2023.
  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.00M shares, a 100.00% increase from fiscal 2022.
  • IQVIA HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 500.00K shares, a 400.00% increase from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-03-312.20M shares
10-Q · filed 2026-05-05
2025-12-312.30M shares
10-K · filed 2026-02-17
2025-09-301.80M shares
10-Q · filed 2025-10-28
2.50M shares
10-Q · filed 2025-10-28
2025-06-303.60M shares
10-Q · filed 2025-07-22
3.00M shares
10-Q · filed 2025-07-22
2025-03-312.20M shares
10-Q · filed 2026-05-05
2024-12-311.00M shares
10-K · filed 2026-02-17
2024-09-301.00M shares
10-Q · filed 2025-10-28
1.00M shares
10-Q · filed 2025-10-28
2024-06-301.10M shares
10-Q · filed 2025-07-22
1.00M shares
10-Q · filed 2025-07-22
2024-03-31800.00K shares
10-Q · filed 2025-05-06
2023-12-311.00M shares
10-K · filed 2026-02-17
2023-09-30900.00K shares
10-Q · filed 2024-10-31
1.00M shares
10-Q · filed 2024-10-31
2023-06-301.20M shares
10-Q · filed 2024-07-22
1.10M shares
10-Q · filed 2024-07-22
2023-03-311.00M shares
10-Q · filed 2024-05-02
2022-12-31500.00K shares
10-K · filed 2025-02-13
2022-09-30400.00K shares
10-Q · filed 2023-11-01
500.00K shares
10-Q · filed 2023-11-01
2022-06-30700.00K shares
10-Q · filed 2023-08-01
500.00K shares
10-Q · filed 2023-08-01
2022-03-31300.00K shares
10-Q · filed 2023-04-28
2021-12-31100.00K shares
10-K · filed 2024-02-15
2021-09-30900.00K shares
10-Q · filed 2022-10-27
900.00K shares
10-Q · filed 2022-10-27
2021-06-301.00M shares
10-Q · filed 2022-07-22
1.00M shares
10-Q · filed 2022-07-22
2021-03-311.00M shares
10-Q · filed 2022-04-28
2020-12-312.40M shares
10-K · filed 2023-02-15
2020-09-302.20M shares
10-Q · filed 2021-10-22
2.50M shares
10-Q · filed 2021-10-22
2020-06-306.20M shares
10-Q · filed 2021-07-28
2.60M shares
10-Q · filed 2021-07-28
2020-03-312.40M shares
10-Q · filed 2021-04-23
2019-12-312.00M shares
10-K · filed 2022-02-16
2019-09-301.70M shares
10-Q · filed 2020-10-22
2.00M shares
10-Q · filed 2020-10-22
2019-06-302.40M shares
10-Q · filed 2020-07-23
2.10M shares
10-Q · filed 2020-07-23
2019-03-311.90M shares
10-Q · filed 2020-04-30
2018-12-311.70M shares
10-K · filed 2021-02-12
2018-09-301.40M shares
10-Q · filed 2019-11-01
1.90M shares
10-Q · filed 2019-11-01
2018-06-302.60M shares
10-Q · filed 2019-07-24
2.20M shares
10-Q · filed 2019-07-24
2018-03-311.80M shares
10-Q · filed 2019-05-02
2017-12-311.40M shares
10-K · filed 2020-02-18
2017-09-301.10M shares
10-Q · filed 2018-10-25
1.70M shares
10-Q · filed 2018-10-25
2017-06-302.40M shares
10-Q · filed 2018-07-27
2.00M shares
10-Q · filed 2018-07-27
2017-03-311.60M shares
10-Q · filed 2018-05-04
2016-12-311.20M shares
10-K · filed 2019-02-19
2016-09-30900.00K shares
10-Q · filed 2017-10-27
916.00K shares
10-Q · filed 2016-11-03
1.40M shares
10-Q · filed 2017-10-27
1.36M shares
10-Q · filed 2016-11-03
2016-06-301.80M shares
10-Q · filed 2017-08-04
1.78M shares
10-Q · filed 2016-07-27
1.60M shares
10-Q · filed 2017-08-04
1.58M shares
10-Q · filed 2016-07-27
2016-03-311.40M shares
10-Q · filed 2017-05-08
1.38M shares
10-Q · filed 2016-05-03
2015-12-311.10M shares
10-K · filed 2018-02-16
1.06M shares
10-K · filed 2016-02-11
2015-09-301.00M shares
10-Q · filed 2016-11-03
1.08M shares
10-Q · filed 2016-11-03
2015-06-301.18M shares
10-Q · filed 2016-07-27
1.11M shares
10-Q · filed 2016-07-27
2015-03-311.04M shares
10-Q · filed 2016-05-03
2014-12-311.20M shares
10-K · filed 2017-02-16
1.24M shares
10-K · filed 2015-02-12
2014-09-301.32M shares
10-Q · filed 2014-10-30
1.23M shares
10-Q · filed 2014-10-30
2014-06-301.60M shares
10-Q · filed 2014-07-31
1.18M shares
10-Q · filed 2014-07-31
2014-03-31766.00K shares
10-Q · filed 2015-04-29
2013-12-311.76M shares
10-K · filed 2016-02-11
2013-09-302.06M shares
10-Q · filed 2014-10-30
1.64M shares
10-Q · filed 2014-10-30
2013-06-301.22M shares
10-Q · filed 2014-07-31
1.42M shares
10-Q · filed 2014-07-31
2013-03-311.63M shares
10-Q · filed 2014-05-01
2012-12-312.36M shares
10-K · filed 2015-02-12
2011-12-311.93M shares
10-K · filed 2014-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B